Literature DB >> 20414709

A two-compartment effect site model describes the bispectral index after different rates of propofol infusion.

Marcus A Björnsson1, Ake Norberg, Sigridur Kalman, Mats O Karlsson, Ulrika S H Simonsson.   

Abstract

Different estimates of the rate constant for the effect site distribution (k(e0)) of propofol, depending on the rate and duration of administration, have been reported. This analysis aimed at finding a more general pharmacodynamic model that could be used when the rate of administration is changed during the treatment. In a cross-over study, 21 healthy volunteers were randomised to receive a 1 min infusion of 2 mg/kg of propofol at one occasion, and a 1 min infusion of 2 mg/kg of propofol immediately followed by a 29 min infusion of 12 mg kg(-1) h(-1) of propofol at another occasion. Arterial plasma concentrations of propofol were collected up to 4 h after dosing, and BIS was collected before start of infusion and until the subjects were fully awake. The population pharmacokinetic-pharmacodynamic analysis was performed using NONMEM VI. A four-compartment PK model with time-dependent elimination and distribution described the arterial propofol concentrations, and was used as input to the pharmacodynamic model. A standard effect compartment model could not accurately describe the delay in the effects of propofol for both regimens, whereas a two-compartment effect site model significantly improved the predictions. The two-compartment effect site model included a central and a peripheral effect site compartment, possibly representing a distribution within the brain, where the decrease in BIS was linked to the central effect site compartment concentrations through a sigmoidal E(max) model.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20414709     DOI: 10.1007/s10928-010-9157-1

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  27 in total

1.  Investigation of effective anesthesia induction doses using a wide range of infusion rates with undiluted and diluted propofol.

Authors:  T Kazama; K Ikeda; K Morita; M Kikura; T Ikeda; T Kurita; S Sato
Journal:  Anesthesiology       Date:  2000-04       Impact factor: 7.892

2.  PsN-Toolkit--a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM.

Authors:  Lars Lindbom; Pontus Pihlgren; E Niclas Jonsson; Niclas Jonsson
Journal:  Comput Methods Programs Biomed       Date:  2005-09       Impact factor: 5.428

Review 3.  Contributions of PK/PD modeling to intravenous anesthesia.

Authors:  C F Minto; T W Schnider
Journal:  Clin Pharmacol Ther       Date:  2008-05-07       Impact factor: 6.875

4.  Steady-state propofol brain:plasma and brain:blood partition coefficients and the effect-site equilibration paradox.

Authors:  S Dutta; Y Matsumoto; A Muramatsu; M Matsumoto; M Fukuoka; W F Ebling
Journal:  Br J Anaesth       Date:  1998-09       Impact factor: 9.166

5.  Population pharmacokinetics of propofol: a multicenter study.

Authors:  J Schüttler; H Ihmsen
Journal:  Anesthesiology       Date:  2000-03       Impact factor: 7.892

6.  A physiologically based, recirculatory model of the kinetics and dynamics of propofol in man.

Authors:  Richard N Upton; Guy Ludbrook
Journal:  Anesthesiology       Date:  2005-08       Impact factor: 7.892

7.  Propofol: relation between brain concentrations, electroencephalogram, middle cerebral artery blood flow velocity, and cerebral oxygen extraction during induction of anesthesia.

Authors:  Guy L Ludbrook; Elizabeth Visco; Arthur M Lam
Journal:  Anesthesiology       Date:  2002-12       Impact factor: 7.892

8.  Comparison of plasma compartment versus two methods for effect compartment--controlled target-controlled infusion for propofol.

Authors:  M M Struys; T De Smet; B Depoorter; L F Versichelen; E P Mortier; F J Dumortier; S L Shafer; G Rolly
Journal:  Anesthesiology       Date:  2000-02       Impact factor: 7.892

9.  Pharmacodynamic modelling of the bispectral index response to propofol-based anaesthesia during general surgery in children.

Authors:  C Jeleazcov; H Ihmsen; J Schmidt; C Ammon; H Schwilden; J Schüttler; J Fechner
Journal:  Br J Anaesth       Date:  2008-02-12       Impact factor: 9.166

10.  The significance of lipoproteins in serum binding variations of propofol.

Authors:  M K Zamacona; E Suárez; E García; C Aguirre; R Calvo
Journal:  Anesth Analg       Date:  1998-11       Impact factor: 5.108

View more
  13 in total

1.  Population pharmacokinetics and pharmacodynamics of propofol in morbidly obese patients.

Authors:  Simone van Kralingen; Jeroen Diepstraten; Mariska Y M Peeters; Vera H M Deneer; Bert van Ramshorst; René J Wiezer; Eric P A van Dongen; Meindert Danhof; Catherijne A J Knibbe
Journal:  Clin Pharmacokinet       Date:  2011-11-01       Impact factor: 6.447

Review 2.  Pharmacokinetic-pharmacodynamic modelling in anaesthesia.

Authors:  Pedro L Gambús; Iñaki F Trocóniz
Journal:  Br J Clin Pharmacol       Date:  2015-01       Impact factor: 4.335

3.  Population pharmacokinetic-pharmacodynamic modeling and dosing simulation of propofol maintenance anesthesia in severely obese adolescents.

Authors:  Vidya Chidambaran; Raja Venkatasubramanian; Senthilkumar Sadhasivam; Hope Esslinger; Shareen Cox; Jeroen Diepstraten; Tsuyoshi Fukuda; Thomas Inge; Catherijne A J Knibbe; Alexander A Vinks
Journal:  Paediatr Anaesth       Date:  2015-05-13       Impact factor: 2.556

4.  Population pharmacokinetic and pharmacodynamic model of propofol externally validated in children.

Authors:  Byung-Moon Choi; Hyun-Gu Lee; Hyo-Jin Byon; Soo-Han Lee; Eun-Kyung Lee; Hee-Soo Kim; Gyu-Jeong Noh
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-02-28       Impact factor: 2.745

Review 5.  Propofol: a review of its role in pediatric anesthesia and sedation.

Authors:  Vidya Chidambaran; Andrew Costandi; Ajay D'Mello
Journal:  CNS Drugs       Date:  2015-07       Impact factor: 5.749

Review 6.  Automation of anaesthesia: a review on multivariable control.

Authors:  Jing Jing Chang; S Syafiie; Raja Kamil; Thiam Aun Lim
Journal:  J Clin Monit Comput       Date:  2014-06-25       Impact factor: 2.502

7.  Propofol Breath Monitoring as a Potential Tool to Improve the Prediction of Intraoperative Plasma Concentrations.

Authors:  Pieter Colin; Douglas J Eleveld; Johannes P van den Berg; Hugo E M Vereecke; Michel M R F Struys; Gustav Schelling; Christian C Apfel; Cyrill Hornuss
Journal:  Clin Pharmacokinet       Date:  2016-07       Impact factor: 6.447

8.  Pharmacokinetic/Pharmacodynamic Model of CW002, an Investigational Intermediate Neuromuscular Blocking Agent, in Healthy Volunteers.

Authors:  Josh D Kaullen; Joel S Owen; Kim L R Brouwer; Paul M Heerdt; Cynthia A Lien; John J Savarese; Virginia D Schmith
Journal:  Anesthesiology       Date:  2018-06       Impact factor: 7.892

9.  Pharmacokinetics and pharmacodynamics of dexmedetomidine-induced vasoconstriction in healthy volunteers.

Authors:  Pekka Talke; Brian J Anderson
Journal:  Br J Clin Pharmacol       Date:  2018-04-02       Impact factor: 4.335

Review 10.  Insights from neuroenergetics into the interpretation of functional neuroimaging: an alternative empirical model for studying the brain's support of behavior.

Authors:  Robert G Shulman; Fahmeed Hyder; Douglas L Rothman
Journal:  J Cereb Blood Flow Metab       Date:  2014-08-27       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.